Adenoma Detection Rate and Clinical Characteristics Influence Advanced Neoplasia Risk after Colorectal Polypectomy

Samir Gupta,Ashley Earles,Ranier Bustamante,Hanin Yassin,Mark Lamm,Sameer Dev Saini,Maria Elena Martinez,Karen Messer,Joshua Demb,Lin Liu,Olga V. Patterson,Andrew J. Gawron,Tonya R. Kaltenbach,Shailja C. Shah,Deborah A. Fisher
DOI: https://doi.org/10.1016/j.cgh.2022.10.003
IF: 13.576
2022-10-20
Clinical Gastroenterology and Hepatology
Abstract:Background and Aims Post-polypectomy risk stratification for subsequent metachronous advanced neoplasia (MAN) is imprecise, and does not account for colonoscopist adenoma detection rate (ADR). Our aim was to assess association of ADR with MAN, and create a prediction model for post-polypectomy risk stratification incorporating ADR and other factors. Methods We conducted a retrospective cohort study of individuals with baseline polypectomy and subsequent surveillance colonoscopy 2004-2016 within the US Department of Veterans Affairs (VA). Clinical factors, polyp findings, and baseline colonoscopist ADR were considered for the model. Model performance [sensitivity, specificity, and area under curve (AUC)] for identifying individuals with MAN was compared to 2020 US Multi Society Task Force on Colorectal Cancer (USMSTF) surveillance recommendations. Results 30,897 individuals were randomly assigned 2:1 into independent model training and validation sets. Increasing age, male gender, diabetes, current smoking, adenoma number, polyp location, adenoma > 10 mm or with tubulovillous/villous features, and decreasing colonoscopist ADR were independently associated with MAN. A range of 1.48 to 1.66-fold increased risk for MAN was observed for ADR in the lowest three quintiles (ADR 47.0%). When the final model selected based on the training set was applied to the validation set, improved sensitivity and specificity over 2020 USMSTF risk stratification were achieved (p<0.001), with an AUC of 0.62 (95% CI: 0.60, 0.64). Conclusion Colonoscopist ADR is associated with MAN. Combining clinical factors and ADR for risk stratification has potential to improve post-polypectomy risk stratification. Improving ADR is likely to improve post-polypectomy outcomes.
gastroenterology & hepatology
What problem does this paper attempt to address?